Dr. Ari Baron, MD
Claim this profileAlta Bates Summit Medical Center-Herrick Campus
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
30 reported clinical trials
68 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
RET positive
2Non-Small Cell Lung Cancer
Stage IV
MET positive
RET positive
Affiliated Hospitals
Clinical Trials Ari Baron, MD is currently running
Combination Therapy
for Multiple Myeloma
This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (daratumumab, lenalidomide and dexamethasone). Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as lenalidomide, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Daratumumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Anti-inflammatory drugs, such as dexamethasone lower the body's immune response and are used with other drugs in the treatment of some types of cancer. Adding bortezomib to daratumumab, lenalidomide, and dexamethasone may be more effective in shrinking the cancer or preventing it from returning, compared to continuing on daratumumab, lenalidomide, and dexamethasone.
Recruiting2 awards Phase 332 criteria
Olaparib
for Pancreatic Cancer
This phase II trial investigates how well the addition of olaparib following completion of surgery and chemotherapy works in treating patients with pancreatic cancer that has been surgically removed (resected) and has a pathogenic mutation in BRCA1, BRCA2, or PALB2. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy.
Recruiting0 awards Phase 232 criteria
More about Ari Baron, MD
Clinical Trial Related8 years of experience running clinical trials · Led 30 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Ari Baron, MD has experience with
- Pembrolizumab
- Nivolumab
- Irinotecan Hydrochloride
- Fluorouracil
- Leucovorin Calcium
- Gemcitabine Hydrochloride
Breakdown of trials Ari Baron, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Pancreatic Cancer
Lung Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ari Baron, MD specialize in?
Ari Baron, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Ari Baron, MD currently recruiting for clinical trials?
Yes, Ari Baron, MD is currently recruiting for 10 clinical trials in Berkeley California. If you're interested in participating, you should apply.
Are there any treatments that Ari Baron, MD has studied deeply?
Yes, Ari Baron, MD has studied treatments such as Pembrolizumab, Nivolumab, Irinotecan Hydrochloride.
What is the best way to schedule an appointment with Ari Baron, MD?
Apply for one of the trials that Ari Baron, MD is conducting.
What is the office address of Ari Baron, MD?
The office of Ari Baron, MD is located at: Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California 94704 United States. This is the address for their practice at the Alta Bates Summit Medical Center-Herrick Campus.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.